title: Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review.
abstract: Taxanes (a class of chemotherapeutic agents) are an important cause of hypersensitivity reactions (HSRs) in cancer patients. During the last decade, the development of rapid drug desensitization has been key to allow patients with HSRs to taxanes to be safely re-treated although the mechanisms of these HSRs are not fully understood. Earlier studies suggested that solvents, such as Cremophor EL used to solubilize paclitaxel, were responsible for HSRs through complement activation, but recent findings have raised the possibility that some of these HSRs are IgE-mediated. Taxane skin testing, which identifies patients with an IgE-mediated sensitivity, appears as a promising diagnostic and risk stratification tool in the management of patients with HSRs to taxanes. The management of patients following a HSR involves risk stratification and re-exposure could be performed either through rapid drug desensitization or graded challenge based on the severity of the initial HSR and the skin test result. Rapid drug desensitization has been shown to be an effective and safe method to re-introduce taxanes in hundreds of patients, including those with life-threatening HSRs. Patients with non-severe delayed skin HSRs may benefit from rapid drug desensitization since they may be at increased risk for an immediate HSR upon re-exposure. This review focuses on the clinical presentation, diagnosis, and novel mechanisms of immediate HSRs to taxanes. A new management strategy for HSRs to taxanes based on skin testing and rapid drug desensitization is proposed.
authors.affiliation: Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 1 Jimmy Fund Way, Smith Building, Boston, MA, 02115, USA.
authors.forename: Matthieu
authors.initials: M
authors.lastname: Picard
authors.affiliation: Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 1 Jimmy Fund Way, Smith Building, Boston, MA, 02115, USA. mcastells@partners.org.
authors.forename: Mariana C
authors.initials: MC
authors.lastname: Castells
mesh_terms: D000818:Animals; D003167:Complement Activation / Q000187:drug effects; D003888:Desensitization, Immunologic; D004342:Drug Hypersensitivity / Q000209:etiology / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced / Q000276:immunology / Q000517:prevention & control*; D007073:Immunoglobulin E / Q000378:metabolism; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy*; D012882:Skin Tests; D043823:Taxoids / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D043823:Taxoids; D007073:Immunoglobulin E
keywords: Abraxane; Allergy; Cabazitaxel; Challenge; Chemotherapy; Complement; Desensitization; Diagnosis; Docetaxel; Hypersensitivity; IgE; Mechanism; Nab-paclitaxel; Paclitaxel; Review; Skin test; Taxane; Taxol; Taxotere
references.citation: Allergy. 2002 Jan;57(1):45-51
references.pmid: 11991289
references.citation: J Allergy Clin Immunol. 2013 Oct;132(4):922-32.e1-16
references.pmid: 23810240
references.citation: Gynecol Oncol. 2001 Sep;82(3):550-8
references.pmid: 11520154
references.citation: Ann Oncol. 1994 May;5(5):468-70
references.pmid: 7915537
references.citation: J Nanomed Nanotechnol. 2013 Feb 18;4(2):1000164
references.pmid: 24163786
references.citation: J Natl Cancer Inst. 2004 Nov 17;96(22):1682-91
references.pmid: 15547181
references.citation: Oncol Lett. 2013 Oct;6(4):881-884
references.pmid: 24137430
references.citation: Oncology. 1998 Jul-Aug;55(4):340-4
references.pmid: 9663424
references.citation: Dermatol Online J. 2013 Aug 15;19(8):19259
references.pmid: 24021438
references.citation: Planta Med. 2002 Jan;68(1):36-40
references.pmid: 11842324
references.citation: Clin Cancer Res. 2006 Feb 15;12(4):1317-24
references.pmid: 16489089
references.citation: J Clin Oncol. 1998 Oct;16(10):3426-32
references.pmid: 9779722
references.citation: J Clin Oncol. 2000 Jan;18(1):102-5
references.pmid: 10623699
references.citation: Support Care Cancer. 2013 Oct;21(10):2679-86
references.pmid: 23686402
references.citation: Anticancer Res. 2004 Mar-Apr;24(2C):1135-7
references.pmid: 15154637
references.citation: Clin Ther. 2013 May;35(5):548-62
references.pmid: 23642289
references.citation: Cancer Res. 1987 May 1;47(9):2486-93
references.pmid: 2882837
references.citation: Gynecol Oncol. 1998 May;69(2):122-4
references.pmid: 9600818
references.citation: J Natl Compr Canc Netw. 2012 Nov 1;10(11):1339-49
references.pmid: 23138163
references.citation: J Rheumatol. 2004 Apr;31(4):818-20
references.pmid: 15088316
references.citation: Clin Rev Allergy. 1991 Fall-Winter;9(3-4):339-55
references.pmid: 1782626
references.citation: Expert Opin Drug Saf. 2010 Jan;9(1):39-53
references.pmid: 20001753
references.citation: Nanomedicine (Lond). 2007 Aug;2(4):415-23
references.pmid: 17716129
references.citation: J Allergy Clin Immunol. 2009 Nov;124(5):1047-54
references.pmid: 19895993
references.citation: Cancer Invest. 2002;20(5-6):666-72
references.pmid: 12197222
references.citation: J Clin Oncol. 1999 Nov;17(11):3403-11
references.pmid: 10550134
references.citation: Ann Oncol. 1996 Nov;7(9):978-9
references.pmid: 9006754
references.citation: Expert Opin Drug Saf. 2011 Jul;10(4):521-8
references.pmid: 21595611
references.citation: J Clin Oncol. 1994 Dec;12(12):2654-66
references.pmid: 7989941
references.citation: Int J Gynecol Cancer. 2009 Oct;19(7):1281-3
references.pmid: 19820391
references.citation: J Clin Oncol. 1995 Oct;13(10):2643-55
references.pmid: 7595719
references.citation: Anticancer Drugs. 2014 Mar;25(3):237-43
references.pmid: 24217332
references.citation: J Allergy Clin Immunol. 1996 Jan;97(1 Pt 1):42-6
references.pmid: 8568136
references.citation: BioDrugs. 2014 Apr;28(2):133-44
references.pmid: 23990250
references.citation: Hematol Oncol Stem Cell Ther. 2013 Sep-Dec;6(3-4):117-9
references.pmid: 24096092
references.citation: Gynecol Oncol. 2006 Jan;100(1):149-51
references.pmid: 16197986
references.citation: Cancer Chemother Pharmacol. 2005 Jul;56(1):91-6
references.pmid: 15791461
references.citation: J Clin Oncol. 1997 Dec;15(12):3517
references.pmid: 9396407
references.citation: J Clin Oncol. 2005 Nov 1;23(31):7794-803
references.pmid: 16172456
references.citation: J Clin Immunol. 2012 Feb;32(1):150-60
references.pmid: 22009002
references.citation: J Control Release. 2008 Dec 18;132(3):171-83
references.pmid: 18582981
references.citation: Nat Rev Drug Discov. 2010 Sep;9(9):677-8
references.pmid: 20811375
references.citation: Anticancer Drugs. 2000 Jun;11(5):331-7
references.pmid: 10912949
references.citation: Future Oncol. 2014 May;10(6):975-83
references.pmid: 24295376
references.citation: Ann Allergy Asthma Immunol. 2013 Sep;111(3):155-62
references.pmid: 23987187
references.citation: Gynecol Oncol. 1995 Feb;56(2):316-8
references.pmid: 7896206
references.citation: J Clin Oncol. 1993 May;11(5):885-90
references.pmid: 8098057
references.citation: Gynecol Oncol. 2005 Nov;99(2):393-9
references.pmid: 16054201
references.citation: J Allergy Clin Immunol. 1978 Feb;61(2):102-7
references.pmid: 621346
references.citation: Ann Allergy Asthma Immunol. 2010 Oct;105(4):259-273
references.pmid: 20934625
references.citation: J Investig Allergol Clin Immunol. 2002;12(4):287-92
references.pmid: 12940232
references.citation: Anticancer Agents Med Chem. 2009 Jan;9(1):109-21
references.pmid: 19149486
references.citation: Curr Oncol. 2013 Oct;20(5):e484-7
references.pmid: 24155645
references.citation: Ann Oncol. 1993 Aug;4(7):610-1
references.pmid: 8103352
references.citation: J Clin Oncol. 1993 Dec;11(12):2456-7
references.pmid: 7902427
references.citation: N Engl J Med. 2008 Apr 17;358(16):1663-71
references.pmid: 18420499
references.citation: Allergy Asthma Proc. 2011 Jan-Feb;32(1):79
references.pmid: 21262103
references.citation: Cancer. 2002 Feb 1;94(3):847-53
references.pmid: 11857321
references.citation: Ann Allergy Asthma Immunol. 2001 Sep;87(3):243-5
references.pmid: 11570623
references.citation: J Investig Allergol Clin Immunol. 2010;20(2):170-1
references.pmid: 20461974
references.citation: Nature. 1994 Feb 17;367(6464):630-4
references.pmid: 7906395
references.citation: Auris Nasus Larynx. 2001 May;28 Suppl:S43-7
references.pmid: 11683342
references.citation: Allergy. 2003 Dec;58(12):1320-1
references.pmid: 14616116
references.citation: Eur J Immunol. 2011 Apr;41(4):1004-13
references.pmid: 21360700
references.citation: J Infect Chemother. 2010 Oct;16(5):340-4
references.pmid: 20354889
references.citation: J Investig Allergol Clin Immunol. 2011;21(2):108-12
references.pmid: 21462800
references.citation: J Chemother. 1999 Oct;11(5):407-9
references.pmid: 10632389
references.citation: Ann Allergy Asthma Immunol. 2009 Feb;102(2):155-60
references.pmid: 19230468
references.citation: Lancet. 2010 Oct 2;376(9747):1147-54
references.pmid: 20888992
references.citation: Nature. 1994 Feb 17;367(6464):593-4
references.pmid: 7906393
references.citation: J Clin Oncol. 2012 Mar 20;30(9):930-5
references.pmid: 22331946
references.citation: Gynecol Oncol. 2006 Jun;101(3):436-40
references.pmid: 16325893
references.citation: Gynecol Oncol. 2011 Jul;122(1):89-94
references.pmid: 21529904
references.citation: J Clin Oncol. 1994 Jun;12(6):1232-7
references.pmid: 7911159
references.citation: Ann Oncol. 1994 Feb;5(2):185-7
references.pmid: 7910480
references.citation: Med Sci Monit. 2006 Nov;12(11):CR462-6
references.pmid: 17072270
references.citation: Cochrane Database Syst Rev. 2011 May 11;(5):CD003911
references.pmid: 21563139
references.citation: Gynecol Oncol. 2005 Mar;96(3):824-9
references.pmid: 15721432
references.citation: J Clin Oncol. 2001 Apr 1;19(7):1901-5
references.pmid: 11283121
references.citation: Br J Cancer. 2004 Jan 26;90(2):304-5
references.pmid: 14974481
references.citation: J Am Chem Soc. 1971 May 5;93(9):2325-7
references.pmid: 5553076
references.citation: Ann Oncol. 2008 Sep;19(9):1547-52
references.pmid: 18436520
references.citation: N Engl J Med. 2004 Oct 7;351(15):1502-12
references.pmid: 15470213
references.citation: Anticancer Drugs. 2000 Aug;11(7):565-8
references.pmid: 11036959
references.citation: J Allergy Clin Immunol. 2004 Aug;114(2):371-6
references.pmid: 15316518
references.citation: Gynecol Oncol. 2002 Mar;84(3):420-5
references.pmid: 11855881
references.citation: Eur J Pharm Sci. 2012 Mar 12;45(4):492-8
references.pmid: 21963457
references.citation: J Oncol Pharm Pract. 2012 Jun;18(2):250-6
references.pmid: 21807762
references.citation: Int Arch Allergy Immunol. 2011;156(3):320-4
references.pmid: 21720178
references.citation: J Drug Deliv. 2013;2013:905091
references.pmid: 23738077
references.citation: Ann Oncol. 1998 May;9(5):573
references.pmid: 9653501
references.citation: Nature. 1979 Feb 22;277(5698):665-7
references.pmid: 423966
references.citation: J Allergy Clin Immunol. 1994 Jan;93(1 Pt 1):117-25
references.pmid: 8308177
references.citation: Gynecol Oncol. 1998 Jan;68(1):25-8
references.pmid: 9454655
references.citation: J Clin Oncol. 1997 Sep;15(9):3149-55
references.pmid: 9294478
references.citation: Ann Oncol. 1997 Jun;8(6):611-4
references.pmid: 9261533
references.citation: J Allergy Clin Immunol. 2006 Feb;117(2):391-7
references.pmid: 16461139
references.citation: Br J Dermatol. 2011 May;164(5):1119-20
references.pmid: 21219296
references.citation: J Allergy Clin Immunol. 2002 Sep;110(3):530
references.pmid: 12209107
references.citation: Cancer J. 2006 May-Jun;12(3):237-45
references.pmid: 16803683
references.citation: Clin Transl Oncol. 2011 Dec;13(12):904-6
references.pmid: 22126735
references.citation: J Allergy Clin Immunol. 2008 Sep;122(3):574-80
references.pmid: 18502492
references.citation: Drug Healthc Patient Saf. 2010;2:1-5
references.pmid: 21701613
references.citation: J Eur Acad Dermatol Venereol. 2009 Nov;23(11):1333-5
references.pmid: 19453796
references.citation: Gynecol Oncol Case Rep. 2013 May 14;5:70-1
references.pmid: 24371703
references.citation: Gynecol Oncol. 2006 Feb;100(2):437-8
references.pmid: 16226797
references.citation: Chemotherapy. 2005 May;51(2-3):116-9
references.pmid: 15886470
references.citation: Cancer Treat Rep. 1986 May;70(5):605-7
references.pmid: 2871928
references.citation: J Natl Cancer Inst. 1995 May 3;87(9):676-81
references.pmid: 7752272
references.citation: Nat Rev Cancer. 2004 Apr;4(4):253-65
references.pmid: 15057285
references.citation: J Natl Cancer Inst. 1998 Feb 18;90(4):300-6
references.pmid: 9486816
references.citation: J Clin Oncol. 1990 Jul;8(7):1263-8
references.pmid: 1972736
references.citation: Onco Targets Ther. 2011;4:123-36
references.pmid: 21792318
references.citation: N Engl J Med. 2013 Oct 31;369(18):1691-703
references.pmid: 24131140
references.citation: J Allergy Clin Immunol Pract. 2013 Sep-Oct;1(5):494-500
references.pmid: 24565621
references.citation: Allergy. 2013 Jul;68(7):853-61
references.pmid: 23647576